Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Allergy Therapeutics plc
Life Sciences
Steady performance in a tough market
By
Dr Martin Hall
13 Jul 2018
Evgen Pharma
Life Sciences
2018, a pivotal year
By
Dr Martin Hall
29 Jun 2018
Stay up-to-date with the latest research
Sign up to our newsletter
genedrive Plc
Life Sciences
Preventing hearing loss in newborns
By
Dr Martin Hall
27 Jun 2018
Avacta Group plc
Life Sciences
Gearing up the management team
By
Dr Martin Hall
26 Jun 2018
Redx Pharma
Life Sciences
“Focus, Realism and Results” – Ian Ross, Chairman
By
Dr Martin Hall
18 Jun 2018
Oxford BioMedica
Life Sciences
Gene-therapy for Parkinson’s: clinical progression
By
Dr Dorothea Hill
14 Jun 2018
Evgen Pharma
Life Sciences
Encouraging interim data from the STEM trial
By
Dr Martin Hall
13 Jun 2018
Incanthera Ltd
Life Sciences
Pre-IPO research – targeting the warheads
By
Dr Martin Hall
12 Jun 2018
Bionomics Ltd
Life Sciences
A big deal in oncology?
By
Dr Martin Hall
04 Jun 2018
Avacta Group plc
Life Sciences
In vivo expression of Affimers
By
Dr Martin Hall
31 May 2018
Bionomics Ltd
Life Sciences
Third Phase II trial of BNC210 begins
By
Dr Martin Hall
30 May 2018
Prev
1
...
8
9
10
11
12
...
17
Next
